No Data
No Data
These 4 Measures Indicate That Elanco Animal Health (NYSE:ELAN) Is Using Debt Extensively
Cautious Hold Rating on Elanco Animal Health Amid Uncertain Growth Prospects
Leerink Partners Maintains Elanco Animal Health(ELAN.US) With Hold Rating, Cuts Target Price to $12
Morgan Stanley Maintains Elanco Animal Health(ELAN.US) With Hold Rating, Cuts Target Price to $13
UBS Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Cuts Target Price to $17
Elanco Animal Health Is Maintained at Equal-Weight by Morgan Stanley